Screening for Patients Admitted to Ain-Shams University Hospitals for SARS-COV-2 (COVID19)
NCT04443712 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1900
Last updated 2020-06-23
Summary
The objective of this study is to screen the patients seeking hospitalization in Ain Shams university hospitals and identify a cost effective tool for continuing screening the patients all through the epidemic period
Conditions
- Coronavirus Disease 2019 (COVID19)
Sponsors & Collaborators
-
Samia Girgis
lead OTHER
Principal Investigators
-
Samia Girgis · Vice Director of ASU Hospital
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-05-29
- Primary Completion
- 2021-06-01
- Completion
- 2021-12-01
Countries
- Egypt
Study Locations
More Related Trials
-
Efficacy and Safety of Direct Anti HCV Drugs in the Treatment of SARS-COV-2 (COVID-19)
NCT04535869 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy of Sofosbuvir Plus Ledipasvir in Egyptian Patients With COVID-19 Compared to Standard Treatment
NCT04530422 ·Status: COMPLETED ·Phase: PHASE3
-
Remdesivir in Adults With Covid-19: Mansoura University Hospital Experience
NCT04728880 ·Status: UNKNOWN
-
Efficacy and Safety of Sirolimus in COVID-19 Infection
NCT04461340 ·Status: UNKNOWN ·Phase: PHASE2
-
Comparison of Tocilizumab Versus Tocilizumab/Infliximab in Patients With COVID-19-associated Cytokine Storm Syndrome
NCT04734678 ·Status: COMPLETED
-
Levamisole and Isoprinosine in Immune-prophylaxis of Egyptian Healthcare Workers Facing COVID-19
NCT04360122 ·Status: UNKNOWN ·Phase: PHASE3
-
Ivermectin In Treatment of COVID 19 Patients
NCT04425707 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of Favipiravir in Management of COVID-19
NCT04349241 ·Status: COMPLETED ·Phase: PHASE3
-
Ivermectin in Treatment of COVID-19
NCT04445311 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Differential Expression of Cytokines, Transcriptome and miRNA in Coronavirus Disease 2019 (COVID-19) Egyptian's Patients
NCT04583566 ·Status: UNKNOWN
-
Levamisole and Isoprinosine in the Treatment of COVID19: A Proposed Therapeutic Trial
NCT04383717 ·Status: UNKNOWN ·Phase: PHASE3
-
Clinical Study to Compare Efficacy and Safety of Casirivimab and Imdevimab Combination, Remdesivir and Favipravir in Hospitalized COVID-19 Patients
NCT05502081 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Sofosbuvir and Daclatasvir Combo in COIVD-19 Patients in Egypt
NCT04773756 ·Status: COMPLETED ·Phase: PHASE4
-
Exchange Transfusion Versus Plasma From Convalescent Patients With Methylene Blue in Patients With COVID-19
NCT04376788 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy of Faviprevir in COVID-19 Treatment
NCT04351295 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Simple Approach to Prevent Hospitalization for COVID-19 Patients
NCT04854824 ·Status: COMPLETED
-
Comparison of Remdesivir Versus Lopinavir/ Ritonavir and Remdesivir Combination in COVID-19 Patients
NCT04738045 ·Status: UNKNOWN ·Phase: PHASE4
-
Lipid Emulsion Infusion and COVID-19 Patients
NCT04957940 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Efficacy of Early Administration of Convalescent Plasma Among COVID-19 Cases in Egypt
NCT04816942 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of the Effect of Convalescent Plasma Therapy in Patients With Life-threatening COVID19 Infection
NCT04438694 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Effect of Pentoxifylline on Prognosis of Coronavirus Disease 2019 (COVID- 19) Infection
NCT04739345 ·Status: COMPLETED ·Phase: NA
-
Prophylactic Ivermectin in COVID-19 Contacts
NCT04422561 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Persistence of Symptoms After Improvement of Acute COVID-19
NCT04764773 ·Status: COMPLETED
-
Sofosbuvir Containing Regimens in Treatment of COVID 19 Patients
NCT04497649 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of Recovered Covid 19 Plasma Transfusion to Covid 19 Severly Ill Patients
NCT04530370 ·Status: UNKNOWN ·Phase: EARLY_PHASE1